Vietnam National Geriatric Hospital
Hanoi, Vietnam
NCT Number: NCT07431528
This project aims to improve knowledge regarding Alzheimer's dementia and related dementias (ADRD) among older adults and their caregivers in Vietnam and promote the early diagnosis of ADRD using a digital storytelling intervention.
Trial opening soon.
Get Notified60 year and older
All sexes
Interventional
Not applicable
Hanoi, Vietnam
This study will develop and test a Digital Storytelling intervention to improve older adults' and caregivers' knowledge of ADRD and to facilitate early diagnosis in rural areas of Vietnam. The Digital Storytelling Intervention includes interactive multimedia modules for motivating behavior change and improving knowledge and attitudes toward ADRD among older adults and their caregivers through the power and voices of patients with mild to moderate ADRD, older persons with cognitive concerns, and their caregivers. Mobile Health technology (Computerized Intervention Authoring System - CIAS) will be used to deliver the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a digital storytelling intervention featuring narratives from older adults with mild to moderate Alzheimer's disease and related dementias (ADRD) and their caregivers who have successfully managed the condition. The stories highlight the benefits of early ADRD diagnosis and strategies for managing diagnostic and care-related challenges. The intervention will be delivered at baseline and biweekly thereafter for three months via CIAS, with didactic "Learn More" modules provided following the stories.
Participants will receive basic information about Alzheimer's disease and related dementias (ADRD), issued by the Vietnam Ministry of Health (usual care), at baseline and at Month 3.
Time frame: Baseline, Month 3, Month 6
Feasibility will be assessed using recruitment and retention records, including the number of participants approached, reasons for ineligibility or refusal, and study completion rates.
Time frame: Month 3, Month 6
Engagement will be assessed using the number of videos watched.
Time frame: Month 6
Information on participants' experiences with the intervention will be collected through exit interviews.
Time frame: Month 3, Month 6
SUS is a 10-item, 5-point Likert scale for subjective assessment of usability. The SUS scores range from 0 to 100. A score of > 50 indicates that the technology-based interventions are acceptable.
Time frame: Baseline, Month 3, Month 6
DKAS is a 25-item scale that evaluates dementia knowledge. Total scores range from 0 to 50, with higher scores indicating greater knowledge.
Time frame: Baseline, Month 3, Month 6
DAS is a 20-item, 7-point Likert scale assessing attitudes toward dementia and people living with dementia. Items are summed, with selected items reverse-coded as appropriate, to calculate a total score (range: 20-140). Higher scores indicate more positive attitudes.
Time frame: Month 3, Month 6
Rates of ADRD screening and diagnosis will be obtained via interviews and through review of participants' medical records by trained study staff. The diagnosis will be reviewed and confirmed by the study co-investigators (physicians).
Time frame: Baseline, Month 3, Month 6
The SF-12 is a 12-item scale that assesses health-related quality of life across physical and mental well-being domains. Scores can range from 0 to 100, with higher scores indicating better quality of life.
Time frame: Baseline, Month 3, Month 6
SC-CII is a 29-item scale assessing self-care behaviors across three domains: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with higher scores indicating better self-care.
Contact information is provided by the study sponsor or research team.
University of Massachusetts, Worcester
Other
Digital Storytelling to Promote Early Dementia Diagnosis in Rural Vietnam
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07200739
Alzheimer Dementia (AD), Alzheimer Disease
Roskilde, Region Sjælland, Denmark
View Trial DetailsNCT07456462
Alzheimer Dementia (AD), Alzheimer Disease
Milan, Milano, Italy
View Trial DetailsNCT07159542
Alzheimer Dementia (AD), Alzheimer Disease
Caen, France
View Trial DetailsNCT07115251
Alzheimer Dementia (AD), Alzheimer Disease
View Trial Details